Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan-Reference-Cited by-同舟云学术

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

Published:2018-05-08 Issue:12 Volume:53 Page:1276-1284
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Toyoda Hidenori^ORCID,Atsukawa Masanori,Takaguchi Koichi,Senoh Tomonori,Michitaka Kojiro,Hiraoka Atsushi,Fujioka Shinichi,Kondo Chisa,Okubo Tomomi,Uojima Haruki,Tada Toshifumi,Yoneyama Hirohito,Watanabe Tsunamasa,Asano Toru,Ishikawa Toru,Tamai Hideyuki,Abe Hiroshi,Kato Keizo,Tsuji Kunihiko,Ogawa Chikara,Shimada Noritomo,Iio Etsuko,Deguchi Akihiro,Itobayashi Ei,Mikami Shigeru,Moriya Akio,Okubo Hironao,Tani Joji,Tsubota Akihito,Tanaka Yasuhito,Masaki Tsutomu,Iwakiri Katsuhiko,Kumada Takashi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-018-1473-z/fulltext.html

Reference42 articles.

1. Bennett H, Waser N, Johnson K, et al. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatol Int. 2015;9:378–90.

2. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med. 1997;127:875–81.

3. Shiffman ML, Hofmann CM, Thompson EB, et al. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. Hepatology. 1997;26:780–5.

4. Shiratori Y, Imazeki F, Moriyama M, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000;132:517–24.

5. Ikeda K, Saitoh S, Arase Y, et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis. Hepatology. 1999;29:1124–30.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study;Hepatology Research;2023-11-28

2. Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance;Annals of Hepatology;2023-03

3. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

4. A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis;Hepatology Research;2022-09-20

5. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06